Roche has announced that its phase 3 IMpower130 study met its co-primary endpoints of overall survival (OS) and progression-free survival (PFS) in non-small cell lung cancer (NSCLC). The combination ...
Think you know iOS inside out? Well, think again. Unlock your iPhone's full potential with these hidden tweaks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results